Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,349 | -34,496 | -26,933 | -17,923 | -8,489 |
| Depreciation Amortization | 464 | 1,614 | 1,125 | 1,417 | 288 |
| Accounts payable and accrued liabilities | 76 | 1,890 | 3,496 | 2,813 | 1,174 |
| Other Working Capital | 1,357 | -383 | -2,146 | -3,533 | -2,288 |
| Other Operating Activity | 1,081 | 3,623 | 409 | -907 | 283 |
| Operating Cash Flow | $-4,372 | $-27,752 | $-24,049 | $-18,133 | $-9,032 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 18,165 | 19,238 | 19,238 | N/A |
| Debt Repayment | -1,513 | -25,728 | -23,858 | -22,842 | -3,140 |
| Common Stock Issued | 833 | 20,337 | 13,178 | 11,922 | 10,461 |
| Financing Cash Flow | $-680 | $12,774 | $8,559 | $8,317 | $7,321 |
| Beginning Cash Position | 26,712 | 41,690 | 41,690 | 41,690 | 41,690 |
| End Cash Position | 21,661 | 26,712 | 26,199 | 31,874 | 39,979 |
| Net Cash Flow | $-5,052 | $-14,978 | $-15,491 | $-9,816 | $-1,711 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,372 | -27,752 | -24,049 | -18,133 | -9,032 |
| Free Cash Flow | -4,372 | -27,752 | -24,049 | -18,133 | -9,032 |